nodes	percent_of_prediction	percent_of_DWPC	metapath
Allylestrenol—PGR—multiple sclerosis	0.494	1	CbGaD
Allylestrenol—PGR—Betamethasone—multiple sclerosis	0.153	0.44	CbGbCtD
Allylestrenol—PGR—Dexamethasone—multiple sclerosis	0.0888	0.256	CbGbCtD
Allylestrenol—Methyltestosterone—Prednisone—multiple sclerosis	0.0757	0.506	CrCrCtD
Allylestrenol—Methyltestosterone—Prednisolone—multiple sclerosis	0.0739	0.494	CrCrCtD
Allylestrenol—CYP3A4—Fingolimod—multiple sclerosis	0.026	0.0748	CbGbCtD
Allylestrenol—CYP3A4—Methylprednisolone—multiple sclerosis	0.0167	0.0482	CbGbCtD
Allylestrenol—CYP3A4—Triamcinolone—multiple sclerosis	0.0127	0.0365	CbGbCtD
Allylestrenol—CYP3A4—Mitoxantrone—multiple sclerosis	0.0122	0.0352	CbGbCtD
Allylestrenol—CYP3A4—Betamethasone—multiple sclerosis	0.0109	0.0313	CbGbCtD
Allylestrenol—CYP3A4—Prednisolone—multiple sclerosis	0.0107	0.0309	CbGbCtD
Allylestrenol—CYP3A4—Prednisone—multiple sclerosis	0.0101	0.0292	CbGbCtD
Allylestrenol—CYP3A4—Dexamethasone—multiple sclerosis	0.00633	0.0182	CbGbCtD
Allylestrenol—Ethynodiol—PGR—multiple sclerosis	0.000828	0.205	CrCbGaD
Allylestrenol—Norelgestromin—PGR—multiple sclerosis	0.000782	0.194	CrCbGaD
Allylestrenol—Desogestrel—PGR—multiple sclerosis	0.000753	0.186	CrCbGaD
Allylestrenol—Norgestimate—PGR—multiple sclerosis	0.000704	0.174	CrCbGaD
Allylestrenol—Levonorgestrel—PGR—multiple sclerosis	0.000431	0.107	CrCbGaD
Allylestrenol—Norethindrone—PGR—multiple sclerosis	0.000349	0.0865	CrCbGaD
Allylestrenol—PGR—Cellular roles of Anthrax toxin—VCAM1—multiple sclerosis	0.000225	0.0458	CbGpPWpGaD
Allylestrenol—ESR1—ATF-2 transcription factor network—IL23A—multiple sclerosis	0.000166	0.0338	CbGpPWpGaD
Allylestrenol—PGR—Ovarian Infertility Genes—VDR—multiple sclerosis	0.000151	0.0307	CbGpPWpGaD
Allylestrenol—PGR—Nuclear Receptors—VDR—multiple sclerosis	0.000131	0.0268	CbGpPWpGaD
Allylestrenol—ESR1—Nuclear Receptors—PGR—multiple sclerosis	0.00011	0.0225	CbGpPWpGaD
Allylestrenol—ESR1—Nuclear signaling by ERBB4—PGR—multiple sclerosis	0.000108	0.022	CbGpPWpGaD
Allylestrenol—PGR—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	0.000104	0.0212	CbGpPWpGaD
Allylestrenol—PGR—Cellular roles of Anthrax toxin—IL1B—multiple sclerosis	0.000104	0.0212	CbGpPWpGaD
Allylestrenol—Norethindrone—ALB—multiple sclerosis	9.82e-05	0.0243	CrCbGaD
Allylestrenol—ESR1—ATF-2 transcription factor network—SELE—multiple sclerosis	9.52e-05	0.0194	CbGpPWpGaD
Allylestrenol—Methyltestosterone—ALB—multiple sclerosis	9.32e-05	0.0231	CrCbGaD
Allylestrenol—ESR1—Nuclear Receptor transcription pathway—PGR—multiple sclerosis	8.72e-05	0.0178	CbGpPWpGaD
Allylestrenol—PGR—Generic Transcription Pathway—ZNF746—multiple sclerosis	8.51e-05	0.0173	CbGpPWpGaD
Allylestrenol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	8.4e-05	0.0171	CbGpPWpGaD
Allylestrenol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	8.4e-05	0.0171	CbGpPWpGaD
Allylestrenol—PGR—Cellular roles of Anthrax toxin—MAPK1—multiple sclerosis	7.91e-05	0.0161	CbGpPWpGaD
Allylestrenol—ESR1—Estrogen Receptor Pathway—STAT3—multiple sclerosis	7.78e-05	0.0159	CbGpPWpGaD
Allylestrenol—ESR1—Nuclear Receptors—VDR—multiple sclerosis	7.71e-05	0.0157	CbGpPWpGaD
Allylestrenol—PGR—Cellular roles of Anthrax toxin—TNF—multiple sclerosis	7.53e-05	0.0154	CbGpPWpGaD
Allylestrenol—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	7.43e-05	0.0152	CbGpPWpGaD
Allylestrenol—ESR1—Validated nuclear estrogen receptor alpha network—PGR—multiple sclerosis	7.27e-05	0.0148	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—ZMIZ1—multiple sclerosis	6.64e-05	0.0136	CbGpPWpGaD
Allylestrenol—ESR1—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	6.09e-05	0.0124	CbGpPWpGaD
Allylestrenol—PGR—Signaling by ERBB4—CD28—multiple sclerosis	6.02e-05	0.0123	CbGpPWpGaD
Allylestrenol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	5.33e-05	0.0109	CbGpPWpGaD
Allylestrenol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	5.33e-05	0.0109	CbGpPWpGaD
Allylestrenol—ESR1—Regulation of nuclear SMAD2/3 signaling—IFNB1—multiple sclerosis	5.3e-05	0.0108	CbGpPWpGaD
Allylestrenol—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	5.26e-05	0.0107	CbGpPWpGaD
Allylestrenol—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	5.26e-05	0.0107	CbGpPWpGaD
Allylestrenol—ESR1—Generic Transcription Pathway—ZNF746—multiple sclerosis	4.99e-05	0.0102	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	4.91e-05	0.01	CbGpPWpGaD
Allylestrenol—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	4.78e-05	0.00976	CbGpPWpGaD
Allylestrenol—ESR1—AP-1 transcription factor network—IL10—multiple sclerosis	4.6e-05	0.00938	CbGpPWpGaD
Allylestrenol—ESR1—Estrogen signaling pathway—MAPK1—multiple sclerosis	4.48e-05	0.00914	CbGpPWpGaD
Allylestrenol—ESR1—AP-1 transcription factor network—IL4—multiple sclerosis	4.48e-05	0.00913	CbGpPWpGaD
Allylestrenol—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	4.32e-05	0.00881	CbGpPWpGaD
Allylestrenol—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	4.32e-05	0.00881	CbGpPWpGaD
Allylestrenol—PGR—Signaling by ERBB4—CD86—multiple sclerosis	4.3e-05	0.00877	CbGpPWpGaD
Allylestrenol—ESR1—Regulation of nuclear SMAD2/3 signaling—VDR—multiple sclerosis	4.21e-05	0.00858	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—ZNF746—multiple sclerosis	4.09e-05	0.00835	CbGpPWpGaD
Allylestrenol—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—multiple sclerosis	4.09e-05	0.00835	CbGpPWpGaD
Allylestrenol—ESR1—AP-1 transcription factor network—HLA-A—multiple sclerosis	4.05e-05	0.00827	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—PTBP1—multiple sclerosis	3.75e-05	0.00764	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—PGR—multiple sclerosis	3.64e-05	0.00742	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—CD28—multiple sclerosis	3.54e-05	0.00721	CbGpPWpGaD
Allylestrenol—ESR1—Plasma membrane estrogen receptor signaling—MMP9—multiple sclerosis	3.49e-05	0.00712	CbGpPWpGaD
Allylestrenol—PGR—Validated nuclear estrogen receptor alpha network—MYC—multiple sclerosis	3.44e-05	0.00702	CbGpPWpGaD
Allylestrenol—ESR1—AP-1 transcription factor network—CCL2—multiple sclerosis	3.18e-05	0.00649	CbGpPWpGaD
Allylestrenol—PGR—Signaling by ERBB4—CD80—multiple sclerosis	3.14e-05	0.0064	CbGpPWpGaD
Allylestrenol—ESR1—ATF-2 transcription factor network—IFNG—multiple sclerosis	3.1e-05	0.00633	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—HNRNPA1—multiple sclerosis	2.84e-05	0.00579	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—U2AF2—multiple sclerosis	2.84e-05	0.00579	CbGpPWpGaD
Allylestrenol—ESR1—FOXM1 transcription factor network—MYC—multiple sclerosis	2.83e-05	0.00577	CbGpPWpGaD
Allylestrenol—ESR1—LKB1 signaling events—MYC—multiple sclerosis	2.78e-05	0.00566	CbGpPWpGaD
Allylestrenol—ESR1—Regulation of Telomerase—IFNG—multiple sclerosis	2.77e-05	0.00565	CbGpPWpGaD
Allylestrenol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	2.75e-05	0.0056	CbGpPWpGaD
Allylestrenol—ESR1—AP-1 transcription factor network—IFNG—multiple sclerosis	2.71e-05	0.00552	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	2.69e-05	0.00548	CbGpPWpGaD
Allylestrenol—PGR—Signaling by ERBB4—TYK2—multiple sclerosis	2.65e-05	0.0054	CbGpPWpGaD
Allylestrenol—ESR1—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	2.63e-05	0.00536	CbGpPWpGaD
Allylestrenol—ESR1—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	2.57e-05	0.00525	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—CD86—multiple sclerosis	2.52e-05	0.00515	CbGpPWpGaD
Allylestrenol—ESR1—Regulation of Telomerase—IL2—multiple sclerosis	2.46e-05	0.00502	CbGpPWpGaD
Allylestrenol—ESR1—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	2.45e-05	0.005	CbGpPWpGaD
Allylestrenol—ESR1—AP-1 transcription factor network—IL2—multiple sclerosis	2.4e-05	0.0049	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—ZNF746—multiple sclerosis	2.4e-05	0.0049	CbGpPWpGaD
Allylestrenol—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	2.3e-05	0.00468	CbGpPWpGaD
Allylestrenol—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	2.3e-05	0.00468	CbGpPWpGaD
Allylestrenol—ESR1—Leptin signaling pathway—IL1B—multiple sclerosis	2.28e-05	0.00466	CbGpPWpGaD
Allylestrenol—ESR1—AP-1 transcription factor network—MMP9—multiple sclerosis	2.28e-05	0.00464	CbGpPWpGaD
Allylestrenol—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	2.26e-05	0.00462	CbGpPWpGaD
Allylestrenol—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	2.26e-05	0.00462	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—ZFP36L1—multiple sclerosis	2.24e-05	0.00458	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—PTBP1—multiple sclerosis	2.2e-05	0.00448	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	2.16e-05	0.0044	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—LINGO1—multiple sclerosis	2.13e-05	0.00434	CbGpPWpGaD
Allylestrenol—ESR1—ATF-2 transcription factor network—MAPK1—multiple sclerosis	2.11e-05	0.0043	CbGpPWpGaD
Allylestrenol—ESR1—Validated nuclear estrogen receptor alpha network—MYC—multiple sclerosis	2.02e-05	0.00412	CbGpPWpGaD
Allylestrenol—ESR1—Regulation of Telomerase—MYC—multiple sclerosis	1.92e-05	0.00392	CbGpPWpGaD
Allylestrenol—ESR1—Regulation of Telomerase—TGFB1—multiple sclerosis	1.92e-05	0.00391	CbGpPWpGaD
Allylestrenol—ESR1—Leptin signaling pathway—STAT3—multiple sclerosis	1.91e-05	0.0039	CbGpPWpGaD
Allylestrenol—ESR1—Regulation of Telomerase—MAPK1—multiple sclerosis	1.88e-05	0.00384	CbGpPWpGaD
Allylestrenol—ESR1—AP-1 transcription factor network—MYC—multiple sclerosis	1.88e-05	0.00383	CbGpPWpGaD
Allylestrenol—ESR1—AP-1 transcription factor network—TGFB1—multiple sclerosis	1.88e-05	0.00382	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	1.85e-05	0.00377	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—TAGAP—multiple sclerosis	1.85e-05	0.00376	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—CD80—multiple sclerosis	1.84e-05	0.00375	CbGpPWpGaD
Allylestrenol—PGR—Generic Transcription Pathway—VDR—multiple sclerosis	1.79e-05	0.00366	CbGpPWpGaD
Allylestrenol—ESR1—Leptin signaling pathway—MAPK1—multiple sclerosis	1.74e-05	0.00355	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—PABPC1—multiple sclerosis	1.74e-05	0.00355	CbGpPWpGaD
Allylestrenol—PGR—Signaling by ERBB4—MAPK1—multiple sclerosis	1.68e-05	0.00344	CbGpPWpGaD
Allylestrenol—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—multiple sclerosis	1.67e-05	0.00341	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—HNRNPA1—multiple sclerosis	1.67e-05	0.0034	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—U2AF2—multiple sclerosis	1.67e-05	0.0034	CbGpPWpGaD
Allylestrenol—ESR1—ATF-2 transcription factor network—IL6—multiple sclerosis	1.62e-05	0.0033	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—S1PR1—multiple sclerosis	1.61e-05	0.00329	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—RPL5—multiple sclerosis	1.57e-05	0.0032	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—GPC5—multiple sclerosis	1.57e-05	0.0032	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—TYK2—multiple sclerosis	1.55e-05	0.00317	CbGpPWpGaD
Allylestrenol—ESR1—Generic Transcription Pathway—PGR—multiple sclerosis	1.51e-05	0.00307	CbGpPWpGaD
Allylestrenol—ESR1—AP-1 transcription factor network—IL6—multiple sclerosis	1.41e-05	0.00288	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—RGS1—multiple sclerosis	1.37e-05	0.0028	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—ZFP36L1—multiple sclerosis	1.32e-05	0.00269	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—GPR65—multiple sclerosis	1.3e-05	0.00265	CbGpPWpGaD
Allylestrenol—PGR—Signaling by ERBB4—IL6—multiple sclerosis	1.29e-05	0.00264	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—LINGO1—multiple sclerosis	1.25e-05	0.00255	CbGpPWpGaD
Allylestrenol—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	1.2e-05	0.00245	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CCR1—multiple sclerosis	1.19e-05	0.00243	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CXCL13—multiple sclerosis	1.19e-05	0.00243	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—TAGAP—multiple sclerosis	1.08e-05	0.00221	CbGpPWpGaD
Allylestrenol—ESR1—Generic Transcription Pathway—VDR—multiple sclerosis	1.05e-05	0.00215	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—PABPC1—multiple sclerosis	1.02e-05	0.00208	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	1.02e-05	0.00207	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	9.94e-06	0.00203	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—MAPK1—multiple sclerosis	9.89e-06	0.00202	CbGpPWpGaD
Allylestrenol—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	9.72e-06	0.00198	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—S1PR1—multiple sclerosis	9.47e-06	0.00193	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—RPL5—multiple sclerosis	9.21e-06	0.00188	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—GPC5—multiple sclerosis	9.21e-06	0.00188	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—VDR—multiple sclerosis	8.63e-06	0.00176	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CCL3—multiple sclerosis	8.47e-06	0.00173	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	8.42e-06	0.00172	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	8.4e-06	0.00171	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	8.24e-06	0.00168	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—PTGER4—multiple sclerosis	8.16e-06	0.00166	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—RGS1—multiple sclerosis	8.05e-06	0.00164	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CXCR3—multiple sclerosis	7.88e-06	0.00161	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	7.84e-06	0.0016	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CD28—multiple sclerosis	7.8e-06	0.00159	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CCR2—multiple sclerosis	7.66e-06	0.00156	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—GPR65—multiple sclerosis	7.63e-06	0.00156	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—IL6—multiple sclerosis	7.6e-06	0.00155	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—PGR—multiple sclerosis	7.25e-06	0.00148	CbGpPWpGaD
Allylestrenol—PGR—Generic Transcription Pathway—MYC—multiple sclerosis	7.13e-06	0.00145	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CNR1—multiple sclerosis	7.07e-06	0.00144	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CCR1—multiple sclerosis	6.98e-06	0.00142	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CXCL13—multiple sclerosis	6.98e-06	0.00142	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CXCL10—multiple sclerosis	6.37e-06	0.0013	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—SRM—multiple sclerosis	5.57e-06	0.00114	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CD86—multiple sclerosis	5.57e-06	0.00114	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CCL5—multiple sclerosis	5.48e-06	0.00112	CbGpPWpGaD
Allylestrenol—CYP3A4—Biological oxidations—POMC—multiple sclerosis	5.16e-06	0.00105	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—SPP1—multiple sclerosis	5.08e-06	0.00104	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—VDR—multiple sclerosis	5.07e-06	0.00103	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CCL3—multiple sclerosis	4.97e-06	0.00101	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CCR5—multiple sclerosis	4.94e-06	0.00101	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—IL2RA—multiple sclerosis	4.87e-06	0.000993	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—PTGER4—multiple sclerosis	4.79e-06	0.000976	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—PGR—multiple sclerosis	4.71e-06	0.000962	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CXCR3—multiple sclerosis	4.62e-06	0.000943	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CD28—multiple sclerosis	4.58e-06	0.000934	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CCR2—multiple sclerosis	4.5e-06	0.000917	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—APOE—multiple sclerosis	4.49e-06	0.000916	CbGpPWpGaD
Allylestrenol—ESR1—Generic Transcription Pathway—MYC—multiple sclerosis	4.18e-06	0.000853	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CNR1—multiple sclerosis	4.15e-06	0.000847	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CD80—multiple sclerosis	4.06e-06	0.000828	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	3.93e-06	0.000801	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	3.93e-06	0.000801	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—POMC—multiple sclerosis	3.86e-06	0.000787	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CCL2—multiple sclerosis	3.78e-06	0.00077	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CXCL10—multiple sclerosis	3.74e-06	0.000762	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—GPC5—multiple sclerosis	3.59e-06	0.000732	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—MYC—multiple sclerosis	3.43e-06	0.0007	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—TYK2—multiple sclerosis	3.43e-06	0.000699	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CD86—multiple sclerosis	3.27e-06	0.000667	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CCL5—multiple sclerosis	3.22e-06	0.000656	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—SPP1—multiple sclerosis	2.98e-06	0.000608	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—RRM1—multiple sclerosis	2.97e-06	0.000607	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CCR5—multiple sclerosis	2.9e-06	0.000591	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—IL2RA—multiple sclerosis	2.86e-06	0.000583	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—IL2—multiple sclerosis	2.85e-06	0.000582	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—MMP9—multiple sclerosis	2.7e-06	0.000551	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—APOE—multiple sclerosis	2.64e-06	0.000538	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—STAT3—multiple sclerosis	2.4e-06	0.00049	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CD80—multiple sclerosis	2.38e-06	0.000486	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—POMC—multiple sclerosis	2.27e-06	0.000462	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—MYC—multiple sclerosis	2.23e-06	0.000455	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—TGFB1—multiple sclerosis	2.23e-06	0.000454	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CCL2—multiple sclerosis	2.22e-06	0.000452	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—MAPK1—multiple sclerosis	2.18e-06	0.000445	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—MYC—multiple sclerosis	2.01e-06	0.000411	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—TYK2—multiple sclerosis	2.01e-06	0.00041	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.71e-06	0.000348	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—IL6—multiple sclerosis	1.68e-06	0.000342	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—IL2—multiple sclerosis	1.67e-06	0.000342	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—MMP9—multiple sclerosis	1.58e-06	0.000323	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—STAT3—multiple sclerosis	1.41e-06	0.000287	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—MYC—multiple sclerosis	1.31e-06	0.000267	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—TGFB1—multiple sclerosis	1.31e-06	0.000266	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—MAPK1—multiple sclerosis	1.28e-06	0.000261	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—APOE—multiple sclerosis	1.03e-06	0.00021	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—IL6—multiple sclerosis	9.84e-07	0.000201	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—POMC—multiple sclerosis	8.83e-07	0.00018	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—ALB—multiple sclerosis	8.05e-07	0.000164	CbGpPWpGaD
